coronavirus
cov
envelop
rna
virus
caus
endem
infect
sever
mammalian
avian
speci
seven
known
human
cov
caus
respiratori
diseas
togeth
account
onethird
common
cold
human
cov
recent
enter
human
infect
anim
sever
acut
respiratori
syndrom
coronaviru
sarscov
middl
east
respiratori
syndrom
coronaviru
merscov
caus
sever
often
fatal
acut
respiratori
syndrom
cov
preval
facil
zoonot
transmiss
potenti
caus
sever
respiratori
diseas
bring
urgenc
research
aim
discov
cov
infect
mechan
mechan
cov
enter
host
cell
subsequ
spread
intercellularli
may
explain
part
remark
expans
virus
new
host
includ
human
entri
spread
carri
spike
glycoprotein
homotrimer
multidomain
integr
membran
glycoprotein
protrud
virion
infect
cell
protein
adher
virus
infect
cell
host
cell
receptor
subsequ
function
catalyst
viruscel
membran
fusion
sever
cov
infect
set
cellcel
membran
fusion
well
respect
adher
step
notabl
mani
cov
protein
contain
multipl
distinct
host
cell
receptorbind
domain
rbd
one
rbd
rais
question
whether
rbd
oper
independ
whether
one
rbd
provid
complet
infect
compet
remain
inact
ie
vestigi
domain
merscov
protein
contain
ntermin
rbd
also
known
domain
structur
similar
galectin
bind
host
cell
sialic
acid
merscov
protein
also
ctermin
rbd
bind
protein
receptor
human
dipeptidyl
peptidas
bind
demonstr
essenti
viruscel
entri
biolog
signific
acid
bind
current
unclear
contrast
murin
hepat
viru
mhv
protein
also
galectinlik
ntermin
rbd
presum
lack
sialic
acid
bind
potenti
instead
bind
protein
receptor
mceacam
mous
carcinoembryon
antigenrel
cell
adhes
molecul
mhv
ctermin
domain
known
receptor
affin
known
control
threshold
smediat
membran
fusion
activ
fact
two
relat
betacov
util
distinct
rbd
host
factor
rais
challeng
develop
gener
model
covcel
bind
membran
fusion
activ
subsequ
infect
one
hypothesi
distinct
rbd
oper
differ
cov
infect
stage
initi
infect
viru
particl
like
requir
durabl
adher
viru
particl
cell
receptor
later
infect
stage
cov
produc
protein
abund
far
exceed
amount
incorpor
secret
progeni
viru
particl
unincorpor
protein
accumul
infectedcel
plasma
membran
depend
cov
strain
mediat
cellcel
fusion
ie
syncyti
develop
rapidli
expand
infect
close
cellcel
contact
may
obviat
need
highaffin
adher
protein
adjac
uninfect
cell
surfac
conceiv
rbd
rel
low
affin
sialic
acid
might
suffici
promot
syncyti
expans
infect
without
requir
highaffin
receptor
interact
put
role
sialic
acid
consid
studi
provid
result
implic
sialic
acid
facilit
cov
infect
cov
cellcel
spread
bring
insight
concern
cov
dissemin
natur
although
cov
strain
compris
mhv
evolv
protein
mceacam
bind
determin
galectinlik
domain
consid
like
mhv
cov
strain
also
retain
sialic
acid
bind
compet
presumpt
came
studi
jhmcov
strain
mhv
jhmcov
infect
mceacam
knockout
mice
mediat
cellcel
fusion
sever
mceacamneg
cell
type
among
cov
jhmcov
strain
document
activ
appar
independ
protein
receptor
make
sensibl
viru
use
address
hypothesi
sialat
protein
receptorbind
activ
coexist
cov
domain
sialic
acidbind
virus
agglutin
erythrocyt
determin
whether
sialic
acid
bind
critic
role
jhmcov
entri
evalu
hemagglutin
human
erythrocyt
use
influenza
viru
hemagglutinin
ha
bear
pseudo
particl
iav
pp
posit
control
jhm
isol
express
incorpor
sialic
acidbind
hemagglutininesteras
protein
viru
particl
select
recombin
jhmcov
lack
express
see
fig
supplement
materi
observ
hemagglutin
could
attribut
protein
intriguingli
viru
particl
agglutin
human
erythrocyt
relat
strain
fig
even
particleassoci
sprotein
input
level
slightli
exceed
correspond
fig
find
suggest
jhm
uniqu
engag
host
sialic
acid
valid
presum
jhm
viru
spikehost
cell
sialic
acid
interact
develop
mhvbase
viruslik
particl
vlp
system
vlp
contain
report
protein
track
viruscel
bind
entri
fig
system
vlp
produc
cell
cotransfect
mhv
structur
gene
e
n
n
gene
modifi
infram
fusion
dualsplit
protein
dsp
encod
sequenc
two
complement
form
renilla
luciferas
rluc
green
fluoresc
protein
gfp
report
allow
releas
vlp
intrins
rluc
gfp
posit
note
mhv
vlp
incorpor
intact
jhm
spike
protein
level
similar
authent
virus
contrast
jhm
spike
incorpor
vesicular
stomat
viru
vsv
base
pseudoparticl
degrad
fig
find
indic
vlp
structur
resembl
authent
viru
structur
least
respect
spike
stabil
particl
incorpor
spike
stabil
multival
present
frequent
requir
detect
sialat
interact
consid
vlp
wellsuit
receptor
bind
studi
addit
vlp
equal
produc
either
without
incorpor
protein
make
possibl
use
vlp
quantifi
sproteindepend
viruscel
bind
process
vlp
either
without
jhm
protein
appli
mceacamneg
hela
cell
equival
rluc
multipl
condit
sprotein
level
vlp
exceed
jhm
vlp
fig
yet
agreement
hemagglutin
effect
virus
jhm
protein
increas
vlphela
cell
bind
background
level
protein
fig
notabl
jhm
vlp
bind
hela
cell
pretreat
neuraminidas
fig
left
suggest
vlp
bind
depend
cellular
sialic
acid
surprisingli
vlp
bind
cell
increas
express
mhv
protein
receptor
mceacam
furthermor
vlp
bind
mceacamexpress
cell
pretreat
neuraminidas
fig
right
togeth
data
suggest
mhvjhm
infect
initi
viral
bind
process
mediat
acid
interact
protein
receptor
mceacam
next
aim
identifi
biolog
import
jhm
spikesial
interact
reason
interact
could
suffici
viral
entri
may
instead
earli
step
preced
viral
engag
protein
mceacam
receptor
assess
viru
entri
util
vlp
contain
n
protein
fuse
one
dsp
fragment
vlp
entri
target
cell
contain
fragment
could
measur
report
complement
activ
rluc
gfp
moieti
fig
compar
vlp
entri
hela
helamceacam
cell
found
rluc
entri
signal
requir
mceacam
presenc
fig
entri
signal
elev
presenc
fig
known
viral
fusiontrigg
proteas
facilit
effect
support
content
vlpbase
entri
assay
faith
reflect
authent
cov
entri
process
conjunct
vlp
bind
data
find
suggest
jhmcov
cell
entri
multistep
process
initi
virussial
bind
subsequ
mceacam
receptordriven
entri
next
determin
whether
viru
bind
sialic
acid
elev
protein
receptordepend
viru
entri
authent
particl
bound
h
dbt
murin
helamceacam
human
bhk
hamster
cell
without
prior
cell
exposur
neuraminidas
infect
measur
quantifi
viral
firefli
luciferas
fluc
report
express
neuraminidas
pretreat
decreas
entri
dbt
helamceacam
bhk
fig
neuraminidas
pretreat
cell
similarli
resist
iav
pp
transduct
vsv
g
protein
vsv
g
contain
pseudoparticl
vsvg
pp
transduct
fig
partial
resist
iav
pp
known
sialic
acidrequir
viru
best
explain
incomplet
remov
sialic
acid
neuraminidas
infer
partial
neuraminidas
resist
cov
vlp
similarli
explain
incomplet
sialic
acid
remov
result
support
model
initi
viru
bind
sialic
acid
facilit
protein
receptormedi
entri
cov
infect
spread
canon
process
progeni
viru
releas
reinfect
also
fusion
ie
syncyti
spread
uninfect
cell
jhm
protein
uniqu
mediat
syncytia
sever
condit
even
mceacam
protein
receptor
absent
determin
whether
sialic
acid
oper
independ
mceacam
receptor
jhm
cellcel
membran
fusion
syncyti
develop
cultur
jhm
covinfect
mous
dbt
cell
mceacamneg
human
hela
cell
separ
harbor
either
hela
cellcel
fusion
would
permit
dsp
complement
activ
rluc
fig
use
livecel
rluc
substrat
develop
activ
rluc
measur
time
presenc
increas
neuraminidas
dose
result
fig
reveal
neuraminidas
dosedepend
reduct
jhm
covinduc
syncytia
highest
neuraminidas
dose
uml
similar
less
pronounc
reduct
observ
parallel
cultur
ceacamposit
hela
cell
fig
note
neuraminidas
treatment
significantli
reduc
cellsurfac
sialic
acid
reveal
adher
fluoresc
wheat
germ
agglutinin
wga
treat
cell
fig
find
conclud
sialic
acid
enabl
cov
smediat
cellcel
fusion
process
without
requir
prototyp
proteinac
receptor
date
analys
multidomain
cov
protein
reveal
domain
interact
sialic
acid
domain
bind
protein
receptor
except
mhv
betacov
domain
bind
protein
ceacam
receptor
find
infer
jhmcov
domain
contain
novel
dualreceptor
bind
capabl
abl
bind
sialic
acid
ceacam
receptor
sialic
acidbind
site
betacov
protein
origin
infer
mutagenesi
studi
recent
structur
resolut
protein
complex
sialosid
mutat
infer
site
decreas
sialosid
bind
even
though
distal
structur
resolv
sialosid
bind
groov
note
mutat
origin
infer
site
among
stretch
four
residu
import
sialatebind
activ
bovin
cov
bcov
jhm
differ
residu
gli
diverg
loop
place
ortholog
bcov
fig
evalu
import
diverg
sialic
acid
bind
construct
mutant
jhmcov
protein
sprotein
express
proteolyt
process
vlp
incorpor
compar
wild
type
wt
fig
notabl
vlp
spike
bound
tightli
hela
cell
spikecontain
vlp
bind
suppress
neuraminidas
pretreat
cell
fig
correl
increas
cell
bind
membran
fusion
compar
syncyti
potenc
jhm
wildtyp
mutant
protein
cellcel
fusion
measur
complement
fig
visual
gfpposit
syncytia
fig
quantifi
measur
rluc
signal
fig
note
mceacam
receptor
present
synyctia
induc
wild
type
mutant
protein
develop
compar
absenc
mceacam
spike
significantli
robust
syncytiuminduc
activ
fig
conclud
singl
point
mutat
jhmcov
domain
increas
cell
bind
membran
fusion
activ
protein
independ
prototyp
jhm
protein
receptor
merscov
domain
bind
host
protein
receptor
merscov
domain
bind
host
sialic
acid
rais
question
whether
merscov
spike
catalyz
cell
fusion
bind
domain
cell
independ
highaffin
protein
receptor
similar
jhmcov
spike
address
question
merscov
smediat
cellcel
fusion
measur
complement
fig
quantifi
measur
rluc
signal
fig
note
syncyti
develop
mediat
merscov
protein
requir
requir
sproteinactiv
proteas
human
fig
catalyt
inact
facilit
cellcel
fusion
fig
mer
smediat
cell
fusion
contrast
gener
protein
bind
sialic
acid
smediat
fusion
absolut
requir
targetcel
human
aminopeptidas
n
hapn
receptor
fig
thu
suffici
cellsurfac
proteas
activ
primari
receptor
dispens
conceiv
secondari
sialatebind
rbd
oper
stage
process
determin
whether
mer
domain
oper
cell
fusion
process
protein
fig
ad
assay
exogen
protein
interf
mer
smediat
fusion
effect
fusion
present
fig
determin
whether
sialic
acid
oper
cell
fusion
process
neuraminidas
ad
assay
exogen
neuraminidas
reduc
merssmedi
fusion
effect
cell
fusion
present
fig
result
suggest
either
two
domain
tether
protein
target
cell
subsequ
cellcel
fusion
distinct
host
receptor
domain
next
determin
whether
analog
chang
relat
merscov
also
modifi
viral
attach
interact
sialic
acid
biolog
signific
antibodi
protect
mice
lethal
merscov
infect
acquir
adapt
mutat
human
mous
model
human
merscov
lung
infect
mice
select
known
glycan
addit
site
document
hypervari
residu
evid
group
merscovrel
bat
virus
absent
bat
viru
group
fig
remark
context
cov
structur
posit
overlap
close
bcov
residu
mhvcov
residu
fig
construct
mer
vlp
determin
whether
chang
impact
cell
bind
initi
test
construct
merscov
vlp
evalu
sialat
bind
properti
human
red
blood
cell
rbc
agglutin
mer
vlp
neuraminidasetr
rbc
fig
indic
vlp
bind
sialosid
construct
wildtyp
vlp
contain
intern
rluc
compar
rluc
sprotein
level
rel
vlp
lack
protein
fig
vlp
appli
human
lungderiv
cell
express
human
receptor
merscov
mous
lungderiv
mous
brainderiv
dbt
cell
neither
express
human
thu
bind
merscov
via
protein
receptor
vlp
bind
assess
quantifi
cellassoci
rluc
chang
chang
vlp
bind
human
cell
clearli
enhanc
vlp
bind
murin
dbt
cell
fig
next
consid
whether
adapt
increas
cell
bind
consequ
mer
smediat
cellcel
membran
fusion
similar
jhmcov
mutant
found
mutant
protein
inde
exhibit
enhanc
cell
fusion
rel
wildtyp
protein
fig
observ
elimin
fig
remov
domin
receptor
interact
demand
util
probe
relationship
bind
cell
fusion
determin
whether
protein
would
suppress
cell
fusion
effect
wt
inde
found
exogen
ad
protein
suppress
cell
fusion
potent
correspond
wildtyp
fig
fig
reinforc
direct
relationship
bind
cell
result
cellcel
fusion
altogeth
find
support
hypothesi
merscov
jhmcov
acquir
increas
cell
bind
mutat
consequ
allow
robust
cellcel
fusion
capabl
cov
procur
cell
bind
cell
fusion
properti
similarli
local
mutat
virus
frequent
begin
infect
attach
cellular
sialic
acid
virus
includ
sever
cov
attach
sialat
via
spike
domain
low
affin
rel
high
multival
avid
atom
resolut
structur
sialic
acid
complex
human
domain
well
sever
sialosid
complex
merscov
reveal
architectur
covsial
bind
site
yet
even
detail
understand
clear
whether
sialic
acid
confer
suscept
cov
infect
whether
proteinac
cov
receptor
also
requir
consid
question
first
focus
murin
mhv
jhmcov
strain
strain
infect
cell
mice
lack
proteinac
mhv
receptor
strain
also
unusu
sensit
proteolyt
activ
spikemedi
membran
fusion
therefor
hypothes
lowaffin
cell
bind
event
conceiv
cellular
sialoglycan
might
suffici
subsequ
jhmcov
proteasetrigg
fusion
activ
cell
entri
found
jhmcov
bind
cell
depend
host
sialic
acid
bind
account
initi
viru
attach
cell
facilit
subsequ
viru
engag
proteinac
ceacam
receptor
later
infect
cycl
jhmcov
spike
facilit
cell
fusion
viru
dissemin
sialic
aciddepend
manner
merscov
spike
protein
could
similarli
fuse
cell
togeth
without
requir
prototyp
protein
receptor
presum
util
sialosid
receptor
engag
neighbor
cell
find
summar
fig
suggest
covcel
entri
intercellular
spread
involv
lectinlik
activ
spike
protein
viruscel
attach
infectedcel
expans
syncytia
sialic
acid
affect
viruscel
bind
infect
jhmcov
cell
entri
merscov
vlp
requir
proteinac
receptor
mceacam
respect
therefor
one
possibl
multival
covsial
interact
suffici
hold
virus
throughout
viru
particlecel
membran
fusion
process
sialic
acid
may
instead
tether
virus
transient
onto
host
cell
surfac
diffus
twodimension
bind
stabli
highaffin
protein
receptor
yet
insuffici
initi
infect
sialic
acid
bind
may
advanc
spikemedi
cellcel
membran
fusion
observ
sever
cov
infect
process
cellcel
fusion
spike
infectedcel
surfac
steadili
direct
uninfect
target
cell
liabl
diffus
away
cellbound
virus
would
yet
still
may
requir
attach
target
cell
sialat
order
effect
membran
fusion
support
content
found
correl
sialic
acid
abund
membran
fusion
activ
observ
jhm
merscov
spike
notabl
jhm
merscov
spikedirect
cell
fusion
took
place
independ
proteinac
receptor
correl
suggest
sialic
acid
uninfect
cell
arrang
spike
oper
cooper
pull
oppos
plasma
membran
coalesc
differenti
util
sialosid
protein
receptor
rais
question
cov
evolut
cov
domain
fold
galectinlik
structur
sever
cov
domain
demonstr
bind
carbohydr
ligand
prior
report
mhvcov
domain
consid
bind
protein
mceacam
receptor
howev
peng
et
al
propos
ancestr
mhvcov
bound
carbohydr
adapt
evolut
gener
presentday
ceacambind
site
propos
infer
exist
past
present
evolutionari
intermedi
capabl
bind
mceacam
sialic
acid
mhv
jhmcov
strain
meet
criteria
viru
singl
domain
retain
two
receptor
bind
activ
one
carbohydr
protein
conceiv
two
receptor
site
interact
increas
affin
one
ligand
reduc
affin
mutant
rel
high
affin
sialic
acid
may
bind
poorli
mceacam
strain
lack
sialic
acid
bind
may
demonstr
strong
mceacam
affin
invers
relationship
would
consist
studi
peng
et
al
propos
acquisit
ceacambind
site
concomitantli
destroy
sialat
site
yet
perhap
intrigu
relationship
cov
hemagglutininesteras
protein
bind
sialosid
esteras
activ
within
protein
deacetyl
sialosid
document
infect
activ
destroy
sspecif
sialosid
receptor
keep
virus
detach
cell
allow
viru
dissemin
sever
mhv
strain
includ
jhm
express
viral
bind
deacetyl
sialiat
similar
mhv
could
destroy
mhv
sialosid
receptor
facilit
dissemin
mhv
strain
bind
sialic
acid
retain
intact
open
read
frame
strain
jhm
bind
sialic
acid
express
suggest
necessari
cov
rel
high
sprotein
affin
sialosid
merscov
bind
sialic
acid
albeit
weakli
increas
affin
sialat
may
limit
absenc
merscov
gene
studi
reveal
sprotein
mutat
may
endow
cov
expand
tropism
beyond
determin
prototyp
proteinac
cov
receptor
jhmcov
mutat
engin
reflect
sialateutil
bcov
increas
viral
sprotein
bind
cell
well
sproteinmedi
membran
fusion
independ
mceacam
merscov
mutat
adapt
viru
growth
mous
lung
oper
remark
similar
jhmcov
chang
mutant
protein
show
increas
cell
bind
cell
fusion
find
fit
hypothesi
virus
mutat
bind
rel
tightli
sialosid
receptor
howev
clear
chang
present
current
identifi
sialosidebind
site
rais
altern
hypothes
includ
mutationinduc
alloster
restructur
sialosidebind
site
altern
mutat
may
restructur
distinct
receptor
coreceptorbind
site
presum
bind
site
ortholog
ceacam
mhv
protein
site
merscov
protein
final
report
illumin
understand
cov
pathogenesi
among
cov
jhmcov
strain
known
caus
lethal
brain
infect
even
mice
lack
princip
mhv
receptor
jhm
spike
identifi
major
contributor
phenotyp
jhmcov
relat
spread
interneuron
vivo
within
vitro
cultur
central
nervou
system
cn
deriv
cell
notabl
neural
cell
membran
known
abund
sialic
acid
content
find
combin
evid
celltocel
syncyti
spread
correl
pathogenesi
sever
infect
model
prompt
hypothesi
jhmcov
sialic
acid
bind
potenti
account
interneuron
syncyti
spread
rapidli
lethal
predict
variant
jhmcov
exhibit
enhanc
sialic
acid
affin
unusu
high
neurovirul
similarli
merscov
strain
caus
lethal
pneumonia
signific
antibodi
specif
merscov
domain
neutral
viru
reduc
infect
pathogenesi
mous
merscov
model
system
conceiv
antibodi
interfer
sialic
acid
bind
reduc
expans
merscov
may
take
place
via
cellcel
fusion
variant
merscov
enhanc
cell
bind
may
use
assess
vivo
signific
find
present
report
atcc
hela
atcc
helamceacam
cell
maintain
fb
medium
dulbecco
modifi
eagl
medium
dmem
contain
mm
hepe
nm
sodium
pyruv
mm
nonessenti
amino
acid
uml
penicillin
g
streptomycin
supplement
fetal
bovin
serum
fb
atlanta
biolog
cell
atcc
maintain
fb
medium
cell
bei
resourc
maintain
fb
medium
lack
hepe
sodium
pyruv
nonessenti
amino
acid
cell
atcc
maintain
fb
medium
minimum
essenti
medium
mem
supplement
fb
uml
penicillin
g
streptomycin
dbt
cell
maintain
fb
medium
mem
supplement
fb
tryptosephosph
broth
mm
sodium
bicarbon
mm
lglutamin
uml
penicillin
g
streptomycin
cell
line
cultur
incub
recombin
mhv
strain
jhmsd
contain
firefli
luciferas
fluc
report
viral
e
envelop
matrix
gene
grown
dbt
cell
media
collect
h
postinfect
aros
laboratori
passag
jhmsd
cov
viruslik
particl
vlp
construct
cotransfect
equimolar
amount
plasmid
encod
cov
e
envelop
matrix
n
nucleocapsid
code
sequenc
e
n
gene
present
genbank
access
jhmcov
genbank
access
merscov
emc
strain
genbank
access
gene
codon
optim
merscov
gene
insert
pcagg
express
vector
plasmid
respect
recombin
construct
fuse
code
sequenc
provid
zene
matsuda
univers
tokyo
follow
sgg
linker
end
code
sequenc
n
gene
express
plasmid
complex
polyethylenimin
pei
polysci
ml
optimem
life
technolog
min
room
temperatur
ad
dropwis
cell
ml
fb
spikeless
vlp
express
plasmid
replac
empti
vector
plasmid
dna
six
hour
later
cell
replenish
fresh
fb
media
collect
h
posttransfect
pseudoviru
particl
pp
construct
vesicular
stomat
viru
vsv
platform
describ
refer
briefli
cell
transfect
viral
glycoprotein
express
plasmid
includ
phefvsv
gindiana
bei
resourc
obtain
lijun
rong
univers
twentyfour
hour
later
cell
inocul
h
vsvdeltagjunin
gpluciferas
cell
rins
twice
fbsfree
dmem
medium
replenish
fb
media
collect
incub
period
media
contain
virus
pseudoviru
particl
vlp
clarifi
differenti
centrifug
g
min
g
min
particl
concentr
clarifi
media
overnight
centrifug
rpm
h
cushion
compris
wtwt
sucros
fbsfree
dmem
result
pellet
resuspend
fbsfree
dmem
result
concentr
particl
stock
store
serial
twofold
dilut
concentr
viru
pseudoviru
particl
stock
prepar
use
fbsfree
dmem
diluent
dilut
sampl
place
vbottom
plate
incub
h
wash
adult
human
erythrocyt
phosphatebuff
salin
pb
ad
score
perform
incub
adher
confluent
cell
plate
rins
pb
fixat
paraformaldehyd
piperazinen
acid
pipe
min
room
temperatur
follow
three
pb
rins
cell
treat
vehicl
neuraminidas
uml
catalog
sigma
neuraminidas
buffer
mm
sodium
acet
naoac
mm
ph
h
cell
rins
three
time
pb
block
pb
contain
fc
pb
fc
min
room
temperatur
use
viru
bind
assay
livecel
assay
adher
confluent
cell
plate
pretreat
vehicl
neuraminidas
uml
catalog
sigma
fbsfree
dmem
h
cell
rins
three
time
pb
use
viru
transduct
assay
vlp
use
bind
assay
prepar
cotransfect
plasmid
encod
cov
e
envelop
matrix
result
vlp
contain
complement
dsp
rlucposit
interior
quantifi
vlpassoci
rluc
vlp
serial
dilut
passiv
lysi
buffer
plb
catalog
promega
introduc
opaqu
micropl
well
per
well
renilla
luciferas
substrat
nacl
mm
mm
mgml
bovin
serum
albumin
coelenterazin
ph
ad
per
well
luminesc
read
use
verita
micropl
luminomet
turner
biosystem
sunnyval
ca
vlp
incub
h
adher
confluent
cell
either
without
prior
neuraminidas
treatment
incub
fbsfree
dmem
known
rluc
vlpcell
ratio
incub
unbound
vlp
remov
cell
rins
variabl
pb
measur
cellbound
vlp
adher
cell
dissolv
plb
rluc
activ
quantifi
vlp
use
entri
assay
prepar
cotransfect
plasmid
encod
cov
e
envelop
matrix
result
vlp
contain
dsp
fragment
interior
quantifi
vlpassoci
dsp
level
vlp
mix
excess
passiv
lysi
buffer
min
allow
dsp
complement
excess
obtain
cell
overexpress
fragment
postlysi
complement
sampl
introduc
opaqu
micropl
well
luminesc
read
use
infer
level
vlp
fbsfree
dmem
inocul
onto
target
cell
transfect
day
earlier
indic
experi
includ
cotransfect
target
cell
vlp
inocul
input
multipl
normal
vlp
level
h
cell
rins
three
time
pb
dissolv
passiv
lysi
buffer
rluc
activ
quantifi
viru
particl
incub
cell
either
without
prior
neuraminidas
treatment
h
cell
rins
three
time
pb
replenish
fbscontain
dmemmem
h
cell
dissolv
lysi
buffer
mm
trisphosph
ph
mm
dithiothreitol
dtt
mm
n
acid
volvol
glycerol
triton
fluc
level
quantifi
fluc
substrat
mm
dluciferin
mm
atp
mm
mm
hepe
ph
verita
micropl
luminomet
effector
target
cell
prepar
introduc
express
plasmid
use
pei
transfect
method
effector
cell
cotransfect
indic
sexpress
plasmid
sexpress
plasmid
includ
genbank
access
obtain
fang
li
univers
minnesota
control
effector
cell
receiv
empti
vector
plasmid
target
cell
cotransfect
indic
receptorexpress
plasmid
plasmid
includ
genbank
access
purchas
origen
genbank
access
obtain
fang
li
indic
experi
includ
addit
cotransfect
target
cell
h
posttransfect
effector
target
cell
rins
pb
lift
trypsin
mix
ratio
cocultur
incub
h
fuse
cell
visual
microscop
green
fluoresc
proteinposit
gfp
cell
extent
cellcel
fusion
quantifi
rluc
activ
present
plb
cell
lysat
sampl
chill
maintain
rluc
quantif
elimin
dsp
postlysi
complement
time
cours
experi
enduren
substrat
promega
use
place
coelenterazin
construct
previous
splice
overlap
extens
pcr
use
insert
mrei
restrict
site
gsgggg
linker
codon
mceacam
codon
human
splice
donor
site
use
modifi
construct
mceacam
code
region
remov
replac
codon
mer
mer
codon
human
signal
follow
mer
codon
cell
transfect
use
pei
method
incub
fbsfree
dmem
contain
wtvol
cell
boost
hyclon
supernat
collect
day
clarifi
sequenti
centrifug
g
min
g
min
fctag
protein
purifi
use
hitrap
protein
highperform
column
ge
healthcar
accord
manufactur
instruct
result
purifi
protein
quantifi
spectrophotometr
store
use
protein
sodium
dodecyl
sulfat
sd
solubil
ph
glycerol
bromophenol
blue
wtvol
sd
heat
min
electrophores
wtvol
polyacrylamidesd
gel
transfer
nitrocellulos
membran
biorad
incub
mous
monoclon
obtain
fumihiro
taguchi
nippon
veterinari
life
scienc
tokyo
japan
mous
emd
millipor
mous
monoclon
antimhv
clone
goat
antihuman
igg
santa
cruz
biotechnolog
incub
appropri
horseradish
peroxidas
hrp
tag
secondari
antibodi
chemiluminesc
substrat
thermo
fisher
blot
imag
process
fluorchem
e
protein
simpl
livecel
imag
captur
z
seri
electronmultipli
chargecoupleddevic
digit
camera
emccd
cascad
photometr
deconvolv
use
softworx
ident
condit
appli
acquisit
deconvolv
imag
analyz
ident
algorithm
imari
bitplan
unless
state
otherwis
experi
repeat
independ
least
three
time
data
point
graph
repres
mean
independ
repeat
n
gener
three
four
technic
repetit
n
statist
comparison
made
unpair
student
test
error
bar
indic
standard
error
data
p
valu
less
consid
statist
signific
